Topic
Bribery
1,328 published works
Global Investigations & Compliance Review
Legal Commentary on the GSK China Bribery Case — From a China Law Perspective
Many thanks to Daniel F. Roules and Rayna Wang of Squire Sanders' Shanghai office for preparing this article. Background Foreign companies doing business in China have focused in recent days…
Global Trade Law Blog
Lessons Learned from the GlaxoSmithKline Bribery Investigation
By: James Zimmerman and Cheryl Palmeri The recent enforcement of Chinese anti-bribery laws against British pharmaceutical company GlaxoSmithKline (GSK) highlights the compliance challenges faced by foreign companies operating in China.…
Global Investigations & Compliance Review
Monthly China Anti-Bribery Update Report—July 2013
The most recent FCPA and anticorruption enforcement developments involving the People’s Republic of China (PRC) are summarized below. Thanks, as always, to Squire Sanders’ Shanghai Office for monitoring these enforcement…
China Law Insight
合规：在华医疗企业和其他高风险企业关注的问题
By King & Wood
作者：金杜律师事务所法律合规组 在过去的几个星期，中国政府部门对一家著名的英国跨国药企采取的一系列行动不断登上了国内和国际媒体的头版头条。中国公安部于7月11日正式宣布，该公司的部分高级管理人员涉嫌为增加产品销量，而通过旅行社向政府官员、医院、医生和医疗行业协会等大肆行贿，目前已对相关人员展开刑事侦查。另外，该声明还指出该公司的一些高管及员工同时涉嫌收受供应商的商业贿赂。 根据新闻报道，此次由公安部统一部署和领导的大规模调查源起于今年6月下旬各地方公安机关对该公司在上海，长沙和郑州的办事处进行的搜查。根据相关报道，此次行动中，公安机关查封了公司的一些文件并且带走了一些员工。 除了媒体报道的此次大规模调查事件外，其他多家医疗领域内的公司近期也受到了政府有关部门在不同层面的调查。另外，国家发展和改革委员会在本月初宣布，将对在中国运营的60家医药公司展开药品成本价的调查。 这一系列针对医疗企业的调查和行动在一定程度上反应了中国政府进一步推动医疗改革的决心，这将对医疗企业产生整体的直接影响。 鉴于此，医疗企业和其他在合规方面存在高风险的企业，比如大量聘请第三方中介机构、频繁接触政府官员或国有企业的公司等，应当高度关注与该事件相关最新动态，并采取适当的应对措施。 在目前的监管环境下，相关企业应高度关注其内部合规制度并确保相关制度得以有效和全面的实施。建议企业着重从以下几个方面审查和完善其合规制度： 审查和更新内部规章制度和流程，包括但不限于关于商务宴请和招待的行为指引、关于应对政府“突袭”检查的指引、员工手册、以及处理内部举报的相关流程等； 向员工提供如何配合政府调查的相关培训； 开展合规及法律风险评估； 对包括财务、会计业务在内的内部控制流程进行审查以及“压力测试”； 主动对涉嫌违规行为进行内部审计和内部调查； 对第三方中介机构，如中介、销售代表等，进行全面的尽职调查； 对被证实的违规行为或举报立即进行处理。 如相关政府部门已经对企业启动了相关调查，那么企业在启动内部评估和审计方案时还应当格外谨慎。
Global Regulatory Enforcement Law Blog
UK Proposes Corporate Sentencing Guidelines
By Eoin O'Shea
For the first time, the UK has proposed a specific and detailed sentencing regime for corporations involved in bribery, fraud and other economic crimes. Of course, individual executives who commit…
Subject to Inquiry
TOTAL – the first joint US/French corruption prosecution
By Government Investigations Group
The TOTAL DPA can therefore be viewed as a case study for general counsel and compliance counsel around the world who may be susceptible to the UK's Bribery Act 2010,…
Global Investigations & Compliance Review
Monthly China Anti-Bribery Update Report—June 2013
The most recent FCPA and anticorruption enforcement developments involving the People’s Republic of China (PRC) are summarized below. Thanks, as always, to Squire Sanders’ Shanghai Office for monitoring these enforcement…
White Collar Crime Prof Blog
In the News & Around the Blogosphere
By Ellen Podgor
Amanda Bronstad, Nat L.J., Report: Bribery Prosecutions Revive Following 2012 LagWalter Pavlo, Forbes, The High Cost Of Mounting A White-Collar Criminal DefenseCovington & Burling, Senior DOJ Criminal Division Official Rejoins…
Global Trade Law Blog
Total Settlement of FCPA Charges
By: Cheryl Palmeri On May 29, 2013, Total, S.A. (Total), the French petroleum corporation, agreed to pay nearly $400 million to resolve charges that it violated the anti-bribery and books…
Global Regulatory Enforcement Law Blog
UK Bribery Act: Reducing the Red Tape
By Rosanne Kay
The Financial Times has reported that a review of the UK Bribery Act is set to be announced next month as the UK government seeks to reduce the cost of…